These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33735299)

  • 1. Effect of population inflow and outflow between rural and urban areas on regional antimicrobial use surveillance.
    Koizumi R; Kusama Y; Muraki Y; Ishikane M; Yamasaki D; Tanabe M; Ohmagari N
    PLoS One; 2021; 16(3):e0248338. PubMed ID: 33735299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Search for Indexes to Evaluate Trends in Antibiotic Use in the Sub-Prefectural Regions Using the National Database of Health Insurance Claims and Specific Health Checkups of Japan.
    Mizuno K; Inose R; Matsui Y; Takata M; Yamasaki D; Kusama Y; Koizumi R; Ishikane M; Tanabe M; Ohge H; Ohmagari N; Muraki Y
    Antibiotics (Basel); 2022 Jun; 11(6):. PubMed ID: 35740169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The first report of Japanese antimicrobial use measured by national database based on health insurance claims data (2011-2013): comparison with sales data, and trend analysis stratified by antimicrobial category and age group.
    Yamasaki D; Tanabe M; Muraki Y; Kato G; Ohmagari N; Yagi T
    Infection; 2018 Apr; 46(2):207-214. PubMed ID: 29273972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The first national survey of antimicrobial use among dentists in Japan from 2015 to 2017 based on the national database of health insurance claims and specific health checkups of Japan.
    Ono A; Ishikane M; Kusama Y; Tanaka C; Ono S; Tsuzuki S; Muraki Y; Yamasaki D; Tanabe M; Ohmagari N
    PLoS One; 2020; 15(12):e0244521. PubMed ID: 33370390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of population age structure on parenteral antimicrobial use estimations.
    Koizumi R; Kusama Y; Asai Y; Tsuzuki S; Aoyagi K; Ishikane M; Muraki Y; Ohmagari N
    Sci Rep; 2023 Jan; 13(1):840. PubMed ID: 36646845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regional Variation of Antimicrobial Use in Japan from 2013-2016, as Estimated by the Sales Data.
    Kusama Y; Ishikane M; Tanaka C; Kimura Y; Yumura E; Hayakawa K; Muraki Y; Yamasaki D; Tanabe M; Ohmagari N
    Jpn J Infect Dis; 2019 Sep; 72(5):326-329. PubMed ID: 31061356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 2018 Global Point Prevalence Survey of antimicrobial consumption and resistance in 47 Canadian hospitals: a cross-sectional survey.
    German GJ; Frenette C; Caissy JA; Grant J; Lefebvre MA; Mertz D; Lutes S; McGeer A; Roberts J; Afra K; Valiquette L; Émond Y; Carrier M; Lauzon-Laurin A; Nguyen TT; Al-Bachari H; Kosar J; Peermohamed S; Science M; Landry D; MacLaggan T; Daley P; McDonald G; Ang A; Chang S; Lin YC; Tong B; Malfair S; Leung V; Katz K; Pauwels I; Goossens H; Versporten A; Conly J; Thirion DJG
    CMAJ Open; 2021; 9(4):E1242-E1251. PubMed ID: 34933882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indications and classes of outpatient antibiotic prescriptions in Japan: A descriptive study using the national database of electronic health insurance claims, 2012-2015.
    Hashimoto H; Saito M; Sato J; Goda K; Mitsutake N; Kitsuregawa M; Nagai R; Hatakeyama S
    Int J Infect Dis; 2020 Feb; 91():1-8. PubMed ID: 31730926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The intended purpose and regional patterns of use of antibiotics for managing Clostridioides (Clostridium) difficile infections: An analysis of the National Database of Health Insurance Claims and Specific Health Checkups data of Japan.
    Inose R; Muraki Y; Kamimoto Y; Kusama Y; Koizumi R; Yamasaki D; Ishikane M; Tanabe M; Ohmagari N
    J Infect Chemother; 2022 Feb; 28(2):356-358. PubMed ID: 34916136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An alternative index for evaluating AMU and anti-methicillin-resistant Staphylococcus aureus agent use: A study based on the National Database of Health Insurance Claims and Specific Health Checkups data of Japan.
    Mita Y; Inose R; Goto R; Kusama Y; Koizumi R; Yamasaki D; Ishikane M; Tanabe M; Ohmagari N; Muraki Y
    J Infect Chemother; 2021 Jul; 27(7):972-976. PubMed ID: 33618976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The quality of antimicrobial prescribing in acute care hospitals: results derived from a national point prevalence survey, Germany, 2016.
    Aghdassi SJS; Schwab F; Hansen S; Peña Diaz LA; Behnke M; Gastmeier P; Kramer TS
    Euro Surveill; 2019 Nov; 24(46):. PubMed ID: 31771705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Use of Topical Antibiotics Based on the National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB) Open Data in 2017.
    Nakanishi T; Inose R; Kusama Y; Ishikane M; Kajihara T; Yahara K; Sugai M; Ohge H; Ohmagari N; Muraki Y
    Jpn J Infect Dis; 2022 Mar; 75(2):177-182. PubMed ID: 34588368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and limitations of national antimicrobial surveillance according to sales and claims data.
    Kusama Y; Muraki Y; Tanaka C; Koizumi R; Ishikane M; Yamasaki D; Tanabe M; Ohmagari N
    PLoS One; 2021; 16(5):e0251299. PubMed ID: 33974635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of a mobile decision support tool on antimicrobial stewardship indicators in St. John's, Canada.
    Doyle D; McDonald G; Pratt C; Rehan Z; Benteau T; Phillips J; Daley P
    PLoS One; 2021; 16(6):e0252407. PubMed ID: 34133424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the appropriate antimicrobial use surveillance tool at the health facility level for Uganda and other low- and middle-income countries?
    Waswa JP; Kiggundu R; Konduri N; Kasujja H; Lawry LL; Joshi MP
    J Glob Antimicrob Resist; 2023 Sep; 34():145-149. PubMed ID: 37423486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of oral third generation cephalosporins and quinolones and occurrence of antibiotic-resistant strains in the neurogenic bladder (NB) outpatient setting: a retrospective chart audit.
    Kitagawa K; Shigemura K; Nomi M; Takami N; Yamada N; Fujisawa M
    Spinal Cord; 2020 Jun; 58(6):705-710. PubMed ID: 31965059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial prescribing and infections in long-term care facilities (LTCF): a multilevel analysis of the HALT 2016 study, Ireland, 2017.
    Tandan M; Burns K; Murphy H; Hennessy S; Cormican M; Vellinga A
    Euro Surveill; 2018 Nov; 23(46):. PubMed ID: 30458910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic prescriptions for Japanese outpatients with acute respiratory tract infections (2013-2015): A retrospective Observational Study.
    Koyama T; Hagiya H; Teratani Y; Tatebe Y; Ohshima A; Adachi M; Funahashi T; Zamami Y; Tanaka HY; Tasaka K; Shinomiya K; Kitamura Y; Sendo T; Hinotsu S; Kano MR
    J Infect Chemother; 2020 Jul; 26(7):660-666. PubMed ID: 32173283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial use and combination of resistance phenotypes in bacteraemic Escherichia coli in primary care: a study based on Japanese national data in 2018.
    Hosaka Y; Muraki Y; Kajihara T; Kawakami S; Hirabayashi A; Shimojima M; Ohge H; Sugai M; Yahara K
    J Antimicrob Chemother; 2024 Feb; 79(2):312-319. PubMed ID: 38084874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.